Lysophosphatidylcholine detection kit and lysophosphatidylcholine detection method
A detection kit, phosphatidylcholine technology, applied in the field of medical detection, to achieve the effect of reducing impurity interference, accurate qualitative and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Method used
Image
Examples
Embodiment 1
[0015] In this embodiment, the lysophosphatidylcholine (LPC) at C20, C22, C24 and C26 in the dried blood spot of the sample is specifically measured by liquid chromatography-tandem mass spectrometry. The specific detection steps are as follows:
[0016] 1) Standard product preparation: Dilute the following standard products with water / methanol / acetonitrile mixture: C18:0, C20:0, C22:0, C24:0. (C18:0 represents stearic acid with 18 carbons and 0 unsaturation) Specifically, water 10%; methanol 60%; acetonitrile 30%.
[0017] 2) Standard blood sheet preparation: take normal goat or bovine whole blood cells, centrifuge at 5000rpm for 10 minutes, remove plasma, add 2 times the volume of PBS, mix with a mixer and let stand for 5 minutes, repeat this step twice to wash the blood cells. Add the blood cells that will be washed in the end, use the same volume of PBS, add the appropriate standard mixture and BHT reagent, and mix well. Take 50ul drops into the filter paper as a standard...
Embodiment 2
[0023] Embodiment 2 contrast experiment to detection background signal
[0024] According to the method of Example 1, common treatment liquid extraction (methanol) (control 1) and mixed treatment (methanol / isopropanol / acetonitrile / internal standard mixed solution 3v:3v:3v:1v) were used for treatment (the present invention). Samples 1 to 5 were extracted and determined, and the test results are shown in Table 1. The extract reagent of the invention can protect and quickly extract the required substances and reduce the interference of impurities.
[0025] Table 1
[0026] Methanol treatment background signal Background signal from mixed reagents sample 1 3120 257 sample 2 5010 301 sample 3 6190 660 sample 4 980 310 Sample 5 1770 270
Embodiment 3
[0027] Quantitative determination of embodiment 3 clinical samples
[0028] According to the method of Example 1, LC-MSMS quantitative determination was performed on the standard substance and samples 1 to 6. The measurement results are shown in Table 2. It can be proved from the table that the method of the present invention can carry out quantitative determination on the samples. The internal standard reference can be qualitative.
[0029] Table 2
[0030]
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
